Abstract
Introduction: Lung cancer is the leading cause of cancer death worldwide, due to its late diagnosis and poor outcome. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional levels by either degrading or blocking translation of messenger RNA targets. Accumulating evidence indicates that miRNAs play a pivotal role in the development and progression of human malignancies, including lung cancer.
Areas covered: In this review, the authors focus on i) application of miRNA-based biomarkers to help classify lung cancer, ii) application of the miRNA biomarkers for the early detection of lung cancer and iii) use of miRNAs as biomarkers to predict outcomes of lung cancer.
Expert opinion: miRNAs provide promising biomarkers for the diagnosis and prognosis of lung cancer. The developed miRNA biomarkers should be comprehensively and prospectively validated in clinical trials before being used in laboratory settings.
Keywords::